HHSN271201100004I - HHSN27100019 IND-enabling studies - ACT1

Ended Awarded Last action

Contract number
HHSN27100019
Awardee
Awarding agency
Obligated
$1,907,639

Award facts

Contract value 100% obligated
$1,907,638.77 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00012 · To administratively DE-obligate unexpended and expiring fiscal year 2020 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30,… -$19,525
Funding Only Action P00011 -$4,726
Other Administrative Action P00010 $0
Funding Only Action P00009 $240,365
Change Order P00008 · POP: 9/18/2015-8/1/2020 HHSN271201100004I - HHSN27100019 IND-enabling studies - ACT1 $119,082
Change Order P00007 $0
Other Administrative Action 6 · POP: 9/18/2015-4/17/2019 HHSN271201100004I - HHSN27100019 IND-enabling studies - ACT1 $0
Change Order 5 $0
Change Order 3 $148,337
Change Order 4 $24,078
Change Order 2 $9,873
Funding Only Action 1 $188,582
Original award $1,201,573
Show all 13

About this award

This is a federal contract award by the National Institute on Drug Abuse (NIDA), a civilian agency, to SRI International, a non-profit research and development institute. The contract is for $1,907,638.77 and involves "Pharmacology and Toxicology for Neurotherapeutics Program (PTNP)" work, specifically "IND-Enabling Studies - ACT1". The award is for the purpose of de-obligating unexpended and expiring fiscal year 2020 funding. SRI International has a robust history of providing advanced scientific and technical services to the U.S. federal government across numerous disciplines. This contract is not associated with a set-aside designation. The contract was originally awarded on September 18, 2015, with an ultimate completion date of August 1, 2020.

Quick answers

Who was awarded contract HHSN27100019?

HHSN27100019 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 18, 2015.

How much is contract HHSN27100019 worth?

The government has obligated $1,907,639 on HHSN27100019.

Is contract HHSN27100019 an order under another contract?

Yes. HHSN27100019 is a delivery order under HHSN271201100004I, an indefinite delivery contract, on Pharmacology and Toxicology for Neurotherapeutics Program (PTNP).

Was contract HHSN27100019 competed?

The extent of competition for HHSN27100019 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award